Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1141 ARTÍCULOS , VIENDO DEL 16 AL 30

Safety, tolerability and pharmacokinetics of the histamine H3 receptor antagonist, ABT-288, in healthy young adults and elderly volunteers

Othman AA, Haig G, Florian H, Locke C, Zhang J, Dutta S.

Br J Clin Pharmacol. 2013 May;75(5):1299-311. doi: 10.1111/j.1365-2125.2012.04472.x.

Low serum vitamin D concentrations in Alzheimer's disease: a systematic review and meta-analysis

Annweiler C, Llewellyn DJ, Beauchet O.

J Alzheimers Dis. 2013;33(3):659-74. doi: 10.3233/JAD-2012-121432.

Platelets in Alzheimer's disease-associated cellular senescence and inflammation

Casoli T, Balietti M, Giorgetti B, Solazzi M, Scarpino O, Fattoretti P.

Curr Pharm Des. 2013;19(9):1727-38.

A randomized phase I study of methanesulfonyl fluoride, an irreversible cholinesterase inhibitor, for the treatment of Alzheimer's disease

Moss DE, Fariello RG, Sahlmann J, Sumaya I, Pericle F, Braglia E.

Br J Clin Pharmacol. 2013 May;75(5):1231-9. doi: 10.1111/bcp.12018.

Design of new drugs for the treatment of Alzheimer's disease based on tacrine structure

de Aquino RA, Modolo LV, Alves RB, de Fatima A.

Curr Drug Targets. 2013 Mar;14(3):378-97. doi: 10.2174/138945013804999043.

β-adrenergic receptors and G protein-coupled receptor kinase-2 in Alzheimer's disease: a new paradigm for prognosis and therapy?

Femminella GD, Rengo G, Pagano G, de Lucia C, Komici K, Parisi V, Cannavo A, Liccardo D, Vigorito C, Filardi PP, Ferrara N, Leosco D.

J Alzheimers Dis. 2013;34(2):341-7. doi: 10.3233/JAD-121813.

Nonselective cation channels and links to hippocampal ischemia, aging, and dementia

MacDonald JF, Belrose JC, Xie YF, Jackson MF.

Adv Exp Med Biol. 2013;961:433-47. doi: 10.1007/978-1-4614-4756-6_37.

The calcium-sensing receptor as a regulator of cellular fate in normal and pathological conditions

Diez-Fraile A, Lammens T, Benoit Y, D'Herde KG.

Curr Mol Med. 2013 Feb;13(2):282-95. doi: 10.2174/156652413804810763.

Once-daily memantine: a guide to its use in moderate to severe Alzheimer's disease in the EU

Lyseng-Williamson KA, McKeage K.

Drugs Aging. 2013 Jan;30(1):51-8. doi: 10.1007/s40266-012-0041-0.

Amyloid β-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression

Butterfield DA, Swomley AM, Sultana R.

Antioxid Redox Signal. 2013 Sep 10;19(8):823-35. doi: 10.1089/ars.2012.5027. Epub 2013 Feb 14.

Tau aggregates as immunotherapeutic targets

Castillo-Carranza DL, Lasagna-Reeves CA, Kayed R.

Front Biosci (Schol Ed). 2013 Jan 1;5(2):426-38. doi: 10.2741/s381.

A comparison of psychosocial outcomes in elderly Alzheimer caregivers and noncaregivers

Mausbach BT, Chattillion EA, Roepke SK, Patterson TL, Grant I.

Am J Geriatr Psychiatry. 2013 Jan;21(1):5-13. doi: 10.1016/j.jagp.2012.10.001. Epub 2013 Jan 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias